Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. - Wikidata - wikimedia - TriplyDB

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.

http://www.wikidata.org/entity/Q44267502

about

Endothelial progenitor cells in diabetic retinopathy Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy.Current and future pharmacological intervention for diabetic retinopathy.Diabetic retinopathy: treatment and prevention.Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4.Biomarkers in Diabetic Retinopathy Effect of macular photocoagulation on visual acuity of Omani patients with clinically significant macular edema.Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies.Modified Lipoproteins in Diabetic Retinopathy: A Local Action in the Retina LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses.Diabetic retinopathy: targeting vasoregression Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids.Diabetic Retinopathy-Update on Prevention Techniques, Present Therapies, and New Leads.Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study.Optimal treatment of diabetic retinopathy.Current concepts in intravitreal drug therapy for diabetic retinopathy.Diabetic retinopathy - An update.Diabetic retinopathy risk prediction for fundus examination using sparse learning: a cross-sectional study.Four-year incidence of diabetic retinopathy in a Spanish cohort: the MADIABETES study Current knowledge on diabetic retinopathy from human donor tissues.Treatment approaches for diabetes and dyslipidemia Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?The predictive role of markers of Inflammation and endothelial dysfunction on the course of diabetic retinopathy in type 1 diabetes Lipotoxicity augments glucotoxicity-induced mitochondrial damage in the development of diabetic retinopathy Tyrosine nitration of prostacyclin synthase is associated with enhanced retinal cell apoptosis in diabetes.Is there a role for hypolipidaemic drug therapy in the prevention or treatment of microvascular complications of diabetes?Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study.High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.Effects of modified LDL and HDL on retinal pigment epithelial cells: a role in diabetic retinopathy?Oxidative and endoplasmic reticulum stresses mediate apoptosis induced by modified LDL in human retinal Müller cells Omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic mice Nutrition for diabetic retinopathy: plummeting the inevitable threat of diabetic vision loss.Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies?Lipid management in Type 1 diabetes.Association of Urinary Phthalates with Self-Reported Eye Affliction/Retinopathy in Individuals with Diabetes: National Health and Nutrition Examination Survey, 2001-2010.1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes.

P2860

Q26827206-E40B6B6E-687C-45F7-8EE5-73EF035DD818 Q27320203-860C2893-E9FA-4640-AAFF-EAFBAB8ABB2F Q28661253-05215292-4C33-41A3-8E0D-D93A2A3EFAD8 Q30433579-95B8926B-7A77-4AAE-BFF3-0E0C1BA5B277 Q33216425-34C008B2-FBA3-4288-A3E3-0B7EF1BFFA33 Q33302529-320488B8-8A9D-4B5E-A0C1-6C6D0E145671 Q33556542-B2803A68-7248-4959-BD82-387C380061FB Q33583030-C32FC6CB-FF03-44FA-8228-461E1F12BED2 Q33645419-6620F90D-88B4-4CBF-9A7B-E19E899C9A3D Q33781706-3BB7DA81-5763-48FE-9555-F2FC75604573 Q33855386-EE3FDB7B-CBA1-4874-BF6A-0A2EC4DD40B6 Q33942486-0296F979-6480-4A1F-8FEB-E69BDF3F8740 Q34300099-6E249770-393A-439F-BEFE-4E1A078FAC3B Q34448837-24CFB5AD-F1B6-4060-A1DE-584DC209FAE2 Q34507297-55A673BC-57FA-4E23-8C6D-12B51ED194E9 Q34553087-96F58F81-9B34-4F44-8453-1BD2DB274495 Q34583297-71E19B72-1158-45D1-8A13-31112913A0EB Q34693503-5D8E8CFE-E74C-407B-BAA9-1973D56799CF Q34957884-C72570B0-22FE-455F-AC1C-C5AC2BB024E5 Q34957902-956C2C2E-83B1-4D7B-9D22-7E22C2FA3F83 Q34986774-8FADAA49-041C-4A81-894C-2EA79A0562CF Q35022756-7AE59496-60FB-4864-8AEC-45CE70DEFFFA Q35179240-1430C460-13E5-4E9C-B3CE-5B5D921D8312 Q35460295-7184B95B-59D8-428A-A371-063FD912AD1D Q35591570-EDE62591-427E-4B76-A985-08E520F4D3BE Q35591658-4317D9E3-BF40-4E9C-8D8D-9559C9E35A8C Q35608796-CC2A23E1-FC7F-4F61-BF6D-BC92BB190838 Q35679391-563E5684-8131-4C4B-9E54-529C4A3CB1C4 Q35871962-FBA2A2C1-903A-4295-82B2-B4A871F00B0F Q35921329-DE882E8E-04A9-44CD-8C20-21B0411433FB Q35976427-7F50F226-DF28-40A3-A42C-A519C56994CA Q36020366-006EE4FC-4C8C-4CF4-9994-C3A33706FA9C Q36089271-AD7FD30D-C60C-4BC2-95DB-B9F9CE5D3D07 Q36128700-061B54FB-4909-49F2-8690-22A2D41D7B95 Q36297109-12097D65-9F8D-4356-826B-71383B6082D6 Q36384149-5BD33B40-D51A-4837-B9D1-2E52EF9E1629 Q36398656-CBB7AA94-E3ED-4C14-B634-70B15435C920 Q36424015-95BA23F8-040B-4BB3-83F4-7692C455F8E7 Q36496258-FB71EDA3-8FC1-4FB2-BB9C-13BC5744FAA9 Q36503844-D90588F4-AB3B-4F4F-A3D2-3C3B960787E2

P2860

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.

http://www.wikidata.org/entity/Q44267502

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.

@en

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.

@nl

type

label

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.

@en

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.

@nl

prefLabel

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.

@en

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.

@nl

P1433

Q44267502-EF3ED2DD-1732-41FE-9783-24F180B4CC17

P1476

Q44267502-DB2B87C7-4FD3-4E07-819B-674D2A8C4C78

P2093

Q44267502-39A71F19-3CBF-4911-AAF6-95A26AB9F70A

Q44267502-413C6DD7-A8EA-4720-A806-3DD18E0EAA80

Q44267502-48E09DEC-3EA3-4EEB-B3C4-ECBE89A75B4C

Q44267502-81FD711F-8E0A-4336-ACEC-36D759A84256

Q44267502-DBC836D3-E698-4181-8E25-1C1F01C947C1

Q44267502-E21DC43E-B8D2-4AEB-B91A-5E2AD4122556

Q44267502-F30E9E0D-0926-412F-B8B1-5AC1629C8469

P304

Q44267502-10420E58-FD5C-490D-8F27-F59207D355F4

P31

Q44267502-E54FC86B-B428-44DE-9DA0-B8ED983BCF26

P356

Q44267502-E221C779-512C-42C9-918C-C0E4961DB20E

P407

Q44267502-C71C6CC0-EACB-4622-8F7D-98E875804F91

P433

Q44267502-42FF93C5-A737-46DE-8797-78BE3FC1BDA2

P478

Q44267502-1510CB56-572E-4461-81F3-547ACC2D4629

P577

Q44267502-C5919F05-7DFF-44BA-84D7-D9BA73DA34B6

P5875

Q44267502-DED62C34-EA5F-43A4-8DFC-EDDBEEA1182B

P698

Q44267502-006EEE97-1615-4603-8D54-C2E29ACF0100

P921

Q44267502-D415E0C7-29B7-40C8-87FA-4F50BEDC8705

P356

P1433

Investigative Ophthalmology & Visual Science

P1476

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.

@en

P2093

Alicia J Jenkins

http://www.w3.org/2001/XMLSchema#string

Daniel McGee

http://www.w3.org/2001/XMLSchema#string

Daniel T Lackland

http://www.w3.org/2001/XMLSchema#string

Deyi Zheng

http://www.w3.org/2001/XMLSchema#string

Richard L Klein

http://www.w3.org/2001/XMLSchema#string

Timothy J Lyons

http://www.w3.org/2001/XMLSchema#string

W Timothy Garvey

http://www.w3.org/2001/XMLSchema#string

P304

910-918

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.02-0648

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8684088

http://www.w3.org/2001/XMLSchema#string

P698

14985310

http://www.w3.org/2001/XMLSchema#string

P921